Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary care by Crilly, Mike et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Health Services Research
Open Access Research article
Gender differences in the clinical management of patients with 
angina pectoris: a cross-sectional survey in primary care
Mike Crilly*1, Peter Bundred2, Xiyuan Hu1, Lisa Leckey3 and 
Fiona Johnstone4
Address: 1Department of Public Health, University of Aberdeen Medical School, Polwarth Building at Foresterhill, Aberdeen, UK, 2Department of 
Primary Care, University of Liverpool Medical School, Whelan Building, Liverpool, UK, 3Liverpool Primary Care Trust, Newhall Campus, 
Longmoor Lane, Liverpool, UK and 4Halton & St. Helens Primary Care Trust, Cowley Hill Lane, St. Helens, Merseyside, UK
Email: Mike Crilly* - mike.crilly@abdn.ac.uk; Peter Bundred - peterb@liverpool.ac.uk; Xiyuan Hu - huxiyuan@yahoo.com; 
Lisa Leckey - lisa.leckey@liverpoolpct.nhs.uk; Fiona Johnstone - fiona.johnstone@hsthpct.nhs.uk
* Corresponding author    
Abstract
Background: Previous research suggests that women admitted to hospital with acute myocardial
infarction (MI) are managed less intensively than men. Chronic stable angina is the commonest
clinical manifestation of coronary heart disease in the community, but little information is available
concerning its contemporary clinical management. The aim of this study is to assess the extent of
gender differences in the clinical management of angina pectoris in primary care.
Methods: A cross-sectional survey undertaken in 8 sentinel centres serving 63,724 individuals in
the city of Liverpool (15% of the city population). Aspects of clinical care assessed included: risk
factor recording (smoking, cholesterol, blood pressure, body mass index); secondary prevention
(aspirin, beta-blocker, statin); cardiac investigation (exercise ECG, perfusion scanning,
angiography); and revascularisation (percutaneous coronary intervention, coronary artery bypass
grafting). Male-to-female adjusted odds ratios (AOR) were calculated (adjusted for age, angina
duration, age at diagnosis and previous MI) using logistic regression.
Results: 1,162 patients (610 men; 552 women) with angina were identified. Women were older
than men (71 vs 67 years), with a shorter duration of angina (6 vs 7 years), and a lower prevalence
of previous MI (25% vs 43%). Men were significantly more likely than women to undergo detailed
risk factor assessment (AOR = 1.35, 95%CI 1.06 to 1.73); receive 'triple' secondary prevention with
aspirin, beta-blockers and statins (AOR = 1.47, 95%CI 1.07 to 2.02); access exercise ECG testing
(AOR = 1.31, 95%CI 1.02 to 1.68); angiography (AOR = 1.61, 95%CI 1.23 to 2.12); and undergo
coronary revascularisation (AOR = 1.93, 95%CI 1.39 to 2.68).
Conclusion: Systematic gender differences exist in the comprehensive clinical management of
patients with angina in primary care.
Background
Previous research has demonstrated that important differ-
ences exist in the clinical management of men and
women with suspected or established coronary heart dis-
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ease (CHD) [1-7]. Most of this research has focused on the
management of acute coronary syndrome (ACS) and the
performance of revascularisation [1-6]. A recent system-
atic review of the diagnosis and treatment of CHD in
women found considerable evidence that women admit-
ted to hospital with ACS are less likely to receive aspirin,
beta-blockers or thrombolysis; less likely undergo exercise
stress testing; and also less likely to undergo angiography
or revascularisation [8]. Although not all studies have
found such gender differences, particularly after adjusting
for important confounding factors such as age [9-13].
Most of the evidence for gender differences in the manage-
ment of CHD relates to specialist care in the USA [1-5,8],
although similar results have also been reported from
hospitals in the UK [14-16]. Women presenting with
angina appear to be at particular risk of receiving sub-opti-
mal care in the hospital setting [4,17]. Despite the atten-
tion that has been focused on such gender differences over
the past 20 years [1], such disparities seem to have
remained largely unchanged in both the USA and UK over
time [5,6].
Angina pectoris is the commonest clinical manifestation
of CHD [18,19], but the management of chronic stable
angina remains a neglected area of cardiovascular research
[18]. Primary care physicians commonly manage angina
in the community and may be predisposed to adopt a less
favourable approach towards the clinical management of
symptomatic women in both the USA and UK [20,21].
Few previous studies have examined gender differences in
the primary care management of angina [22,23]. It is cur-
rently unclear as to what extent gender differences
observed in hospital management are also present in the
clinical care of patients with chronic stable angina in the
community [8]. The aim of this study is to examine the
influence of gender on the comprehensive clinical man-
agement of angina pectoris from a primary care perspec-
tive in the UK.
Methods
This study reports a cross-sectional survey, undertaken by
specially trained clinical data managers, of patients in pri-
mary care with an explicit and unequivocal physician
diagnosis of angina pectoris.
Sentinel primary care centres
Since 1992 several primary care centres across the city of
Liverpool (sentinel practices) have employed a clinical
data manager (CDM) as an additional member of their
healthcare team. The CDMs have a remit for collecting
anonymised individual patient data from primary care (as
part of the Liverpool Primary Care Data Project) having
undergone advanced training in data handling in the
Department of Primary Care at Liverpool University.
Data collection was undertaken by 7 experienced CDMs
(average of 6 years experience) attached to 8 sentinel prac-
tices (one CDM covered two practices). The sentinel prac-
tices served a combined registered population of 63,724
(15% of a city population of 439,473) and cover a range
of geographical areas, from the most affluent to the most
deprived parts of the city. The sentinel practices had par-
ticipated in the primary care data collection project for
between 6–9 years. All practices were computerised and
ranged in size from 2,369 to 12,885 registered patients
(median 8,307). Their combined age-sex profile was sim-
ilar to the city as a whole, but with relatively fewer adults
aged over 50 years compared with England (46% vs 54%).
Information was extracted by the CDMs according to a
standardised protocol. The quality of the data-collection
process was overseen by an informatics co-ordinator. Data
was collected using a controlled entry Microsoft Access
Form within each practice. Data collection was piloted
with 10 patients from each practice before the start of the
study. The main study took 3-months (11 September to
18 December 2001). At the time of the study UK clinical
guidelines did not recommend the use of ACE inhibitors
[24] and statins were only available on prescription.
Patients with angina
Patients prescribed any nitrate preparation over the previ-
ous 3 years (sub-lingual nitrates, tablets or patches as
listed in the British National Formulary, BNF) were iden-
tified by searching the clinical computer systems. The
CDMs reviewed both computerised and written medical
records and extracted information only for those patients
explicitly and unequivocally labelled with a physician
diagnosis of angina pectoris. We considered such patients
to have 'clinically certain angina' as described in evidence-
based guidelines concerning the clinical management of
chronic stable angina in UK primary care [24]. We
excluded patients where there was any recorded doubt or
disagreement concerning the diagnosis.
In addition to age, sex and the date of angina diagnosis,
the CDMs also extracted information concerning the four
major aspects of CHD care: (1) coronary risk factor
recording (smoking, cholesterol, blood pressure and body
mass index, BMI) (2) secondary prevention with aspirin,
statin, beta-blocker; (3) cardiac investigation, including
exercise ECG testing, thallium scanning, coronary angiog-
raphy; (4) revascularisation with coronary artery bypass
grafting (CABG) and/or percutaneous coronary interven-
tion (PCI). Any previous history of myocardial infarction
(MI) was identified. The number of face-to-face physician
contacts in primary care over the previous 12 months was
recorded. Data was also extracted concerning the current
prescription of beta-blockers and statins (medication pre-
scribed within the previous 6 months was considered to
be current). Since aspirin can be purchased without a pre-BMC Health Services Research 2007, 7:142 http://www.biomedcentral.com/1472-6963/7/142
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scription over-the-counter, the 'advised, prescribed or pre-
vious' use of 'once daily aspirin' was noted. Contra-
indications to aspirin use were also recorded.
Statistical analysis
Odds ratios (OR) are used to summarise relative gender
differences. An OR of 1.0 indicates no gender difference
(greater than 1.0 favours men; less than 1.0 favours
women). Adjusted male/female odds ratios (AOR) and
their 95% confidence intervals were calculated using mul-
tiple logistic regression (SPSS v10). OR's were adjusted for
current age, duration of angina (both in years) and previ-
ous MI. This also adjusted for age at diagnosis (current age
minus angina duration). In a secondary analysis the
annual number of physician contacts was included in the
regression model.
The study complies with the Declaration of Helsinki. Eth-
ical approval was obtained for the Liverpool Primary Care
Data Project (the presence of clinical data managers in pri-
mary care sentinel practices with the collection and com-
pilation of anonymised individual patient data) at its
inception in 1992 from the appropriate Local Research
Ethics Committees in Liverpool. Separate ethical approval
was not required for the analysis of anonymised patient
data reported in this study. Since the original ethical
approval was only for the collection of anonymised indi-
vidual patient data, it is not possible to link individual
patient data with routinely available data concerning sub-
sequent hospital admission or death certification.
Results
The 8 sentinel practices had a combined registered popu-
lation of 63,724 (31,977 aged 30 years or more). In the
preceding 3 years 1,782 patients had received a nitrate
prescription, of which 1,177 (66%) had been explicitly
and unequivocally labelled as having angina pectoris
(clinically certain angina). Their ages ranged from 32 to
95 years (94% were aged 50 years or more). The preva-
lence of nitrate treated angina was 3.7% (95%CI 3.5% to
3.9%) in those aged 30 years or more. 1,162 patients (610
men; 552 women) are included in this analysis (15
patients were excluded due to date of birth errors).
Characteristics of patients with angina
There were important clinical differences between men
and women with angina (see Table 1). Women were on
average 3.6 (95%CI 2.3 to 4.8) years older than men; had
a higher annual physician consultation rate (Mann-Whit-
ney U test, p < 0.001); and had been 4.3 (95%CI 3.0 to
5.6) years older at diagnosis. Men had a longer duration
of angina (a median of 6-months longer duration; Mann-
Whitney U test, p = 0.01) and a higher prevalence of pre-
vious myocardial infarction (43% vs 25%; absolute differ-
ence 18.6%, 95%CI 13.2% to 23.9%).
Overall clinical management of angina
The clinical care provided to patients with angina is
shown in Table 2 and Figure 1. The overall recording of
cardiac risk factors was high. Smoking habit, blood pres-
sure and cholesterol was recorded for more than 85% of
patients, whilst BMI recording was somewhat lower
(72%). Statins were prescribed to 55% of patients and
'once daily aspirin' was advised/prescribed to 84% of
patients. Beta-blockers were currently prescribed to 35%
of angina patients with a previous MI, which was similar
to the use of beta-blocker by all patients (33%). Some
48% of patients with angina had undergone exercise ECG
Bar chart of the clinical management of angina pectoris by  gender (N = 1,162) Figure 1
Bar chart of the clinical management of angina pectoris by 
gender (N = 1,162).
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Table 1: Characteristics of men and women with angina pectoris 
(N = 1,162)
Men Women
n = 610 n = 552
Mean age, 
years (SD)
66.9 10.9 70.5 11.1
Mean age at 
diagnosis, 
years (SD)
58.8 10.9 63.1 11.8
Median 
duration of 
angina, 
years (IQR)
6.9 (3.5–11.4) 6.3 (2.8–10.6)
Median 
physician 
contacts 12 
months 
(IQR)
7 (4–10) 8 (5–13)
Previous 
Myocardial 
Infarction, 
MI
265 43% 137 25%
SD, standard deviation; IQR, interquartile range.BMC Health Services Research 2007, 7:142 http://www.biomedcentral.com/1472-6963/7/142
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testing; 21% coronary angiography; and 19% revasculari-
sation (9% PCI; 12% CABG)
Gender differences in angina management
Men received higher levels of care for their angina for
almost all aspects of clinical management. Men were
more likely to have their individual cardiac risk factors
recorded (except for blood pressure measurement which
was the same for both sexes) and were more likely to have
all four risk factors recorded (Table 2). Men also received
a higher level of secondary prevention therapy with aspi-
rin, statins and beta-blockers. They were also more likely
to have undergone further cardiac investigation and revas-
cularisation. (Figure 1) The largest 'absolute' gender dif-
ferences were in the performance of exercise ECG testing
(12.6%, 95%CI 6.8% to 18.2%); coronary angiography
(9.5%, 95%CI 4.9% to 14.1%), coronary revascularisa-
tion (13.0%, 95%CI 8.5% to 17.3%), and beta-blocker
use by angina patients with a previous MI (absolute differ-
ence 15.1%, 95%CI 5.5% to 24.0%). The corresponding
relative gender differences (odds ratios) are shown in
Table 2.
Adjusted comparison of gender differences
Duration of angina was unavailable for only one patient
and consequently 1,161 patients were included in multi-
ple logistic regression analysis (adjusted for age, angina
duration and previous MI). All the adjusted odds ratios
(AOR) were closer to unity than unadjusted OR's (Table
2). The AOR's are shown in Figure 2.
Forest plot of the clinical management of angina pectoris:  male-to-female odds ratios adjusted for age, duration of  angina and previous myocardial infarction (N = 1,162) Figure 2
Forest plot of the clinical management of angina pectoris: 
male-to-female odds ratios adjusted for age, duration of 
angina and previous myocardial infarction (N = 1,162).
Table 2: Gender differences in the clinical management of angina pectoris in primary care, N = 1,162 (a male:female odds ratio greater 
than one favours the clinical management of male angina)
Men Women Unadjusted Adjusted*
(n = 610) % (n = 552) % Odds Ratio Odds 
Ratio
95%CI
Risk Factor Recording
Smoking habit 562 92 493 89 1.40 1.12 0.74 to 1.71
Cholesterol 545 89 453 82 1.83 1.46 1.02 to 2.07
BP previous 12 months 537 88 484 88 1.03 0.99 0.69 to 1.43
Body Mass Index 456 75 381 69 1.33 1.18 0.90 to 1.54
All 4 risk factors recorded 393 64 302 50 1.50 1.35 1.06 to 1.73
Secondary Prevention
Aspirin 527 86 447 81 1.49 1.35 0.97 to 1.86
Statin 344 56 290 53 1.17 0.92 0.72 to 1.18
Beta Blocker 231 38 155 28 1.56 1.43 1.10 to 1.86
Aspirin+Statin+Beta Blocker 138 23 80 14 1.73 1.47 1.07 to 2.02
Beta Blocker (prior MI, n = 402) ** 106 40 34 25 2.02 1.83 1.12 to 3.00
Investigation
Exercise Electrocardiograph 332 54 231 42 1.66 1.31 1.02 to 1.68
Coronary Angiography 228 37 123 22 2.08 1.61 1.23 to 2.12
Thallium Scan 15 2.5 10 1.8 1.37 1.12 0.48 to 2.63
Revascularisation
PCI or CABG or Both 152 25 66 12 2.44 1.93 1.39 to 2.68
CABG 96 16 38 7 2.53 2.02 1.33 to 3.06
PCI 70 11 34 6 1.97 1.59 1.02 to 2.49
Adjusted odds ratios based on 1,161 complete cases (one patient lacked date of diagnosis for angina); 95%CI, 95% confidence interval; BP, blood 
pressure; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.
* Odds Ratios adjusted (AOR) for age, duration of angina and previous MI using multiple logistic regression.
** Previous Myocardial Infarction (MI), n = 402 (265 men; 137 women): odds ratio adjusted for age and duration of angina.BMC Health Services Research 2007, 7:142 http://www.biomedcentral.com/1472-6963/7/142
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Risk factor recording and secondary prevention
Men were significantly more likely to have all four risk fac-
tors recorded (AOR 1.35, 95%CI 1.06 to 1.73). The higher
use of aspirin by men (AOR 1.35, 95%CI 0.97 to 1.86)
was not accounted for by gender differences in the preva-
lence of contra-indications to aspirin (e.g. previous his-
tory of peptic ulceration/dyspepsia was similar for men
and women; 11.7% v 12.9%). Men were also significantly
more likely to be prescribed a beta-blocker, a gender gap
that was wider for those with a previous MI (AOR 1.83,
95%CI 1.12 to 3.00). Men were also significantly more
likely than women to be prescribed 'triple secondary pre-
vention' with 'aspirin, statin and beta-blocker' (AOR 1.47,
95%CI 1.07 to 2.02). Statin use was the only aspect of
clinical management that (non-significantly) favoured
women (AOR 0.92, 0.72 to 1.18).
Investigation and Revascularisation
Further cardiac investigation, with exercise-ECG testing
and coronary angiography, was significantly higher for
men (AOR 1.31 and 1.61 respectively). Thallium scanning
was an uncommon investigation, but its limited clinical
use also favoured men (AOR 1.12, not statistically signifi-
cant). Men were significantly more likely than women to
undergo revascularisation with both CABG and PCI (AOR
2.02 and 1.59 respectively). Overall the use of any of these
cardiac investigations was significantly higher for men
than for women (AOR 1.56, 95%CI 1.21 to 2.01).
Physician contact
Including the annual number of primary care physician
contacts in the regression model made no important dif-
ference to most of the AOR's reported in Table 2. For
example, the AOR for aspirin use and revascularisation
were 1.36 and 1.98 respectively (compared with 1.35 and
1.93 respectively). But adjusting for annual physician con-
tact consistently widened the gender gap in relation to the
more favourable recording of cardiac risk factors for men
(Table 3). The largest changes occurred in relation to the
recording of BP and smoking habit (AOR 1.29 and 1.43
respectively).
Discussion
In this study, women with 'clinically certain angina'
received significantly less favourable cardiac care than
comparable men across a range of clinically important
measures. Women were less likely to have their cardiac
risk factor recorded, receive secondary prevention therapy,
be referred for further cardiac investigation, or undergo
revascularisation. These gender differences remained after
adjusting for the older age of women with angina, their
lower prevalence of a prior MI, longer duration of angina,
and older age at diagnosis.
Chronic stable angina
Only two previous studies have examined gender differ-
ences in the management of chronic stable angina in pri-
mary care and adjusted for important confounding factors
such as age and previous MI [22,23]. We have reported a
similar gender pattern in the management of angina in
primary care 6 years previously, although a smaller sam-
ple size meant that only sex differences in the use of aspi-
rin, exercise testing and revascularisation were statistically
significant (AOR 2.07, 1.56 and 1.71 respectively) [22]. In
our previous study women were also significantly less
likely to be assessed by a cardiac specialist and were more
likely to be managed entirely within primary care [22]. A
larger Scottish study using routinely collected data has
demonstrated a greater use of aspirin, statins and beta-
blockers for men with angina, (AOR 1.21, 1.20 and 1.16
respectively), but did not assess risk factor recording, car-
diac investigation or revascularisation [23]. Whilst a hos-
pital-based study in England of the clinical investigation
of angina found a greater use of exercise testing, angiogra-
phy and revascularisation for men (AOR 2.65, 2.42, 2.80
respectively) [7].
Coronary heart disease in primary care
Five UK studies have looked at specific aspects of CHD
management in primary care and adjusted (at least) for
age as a confounding factor [25-29]. Such studies have
commonly used large prescribing databases without vali-
dating the diagnosis of CHD [25-28,30], or distinguishing
between patients with angina, prior MI, or both [25-29].
Distinguishing between patients with 'angina alone',
'angina and prior MI' and 'prior MI-alone' is important,
because hospital admission with an acute MI is likely to
Table 3: Influence of physician contact on gender differences for 
cardiac risk factor recording in 1,161 patients with angina 
pectoris (odds ratio greater than one favours the recording of 
cardiac risk factors for men)
Adjusted Odds 
Ratios (95%CI)
Adjusted Odds 
Ratios (95%CI) 
also adjusted for 
annual physician 
contact
N = 1,161 N = 1,155
Body Mass Index 1.18 (0.90 to 1.54) 1.27 (0.96 to 1.67)
BP previous 12 
months
0.99 (0.69 to 1.43) 1.29 (0.88 to 1.90)
Smoking habit 1.12 (0.74 to 1.71) 1.43 (0.92 to 2.22)
Cholesterol 1.46 (1.02 to 2.07) 1.68 (1.17 to 2.42)
All 4 risk factors 
recorded
1.35 (1.06 to 1.73) 1.50 (1.17 to 1.93)
BP, blood Pressure; 95%CI, 95% confidence interval.
All Odds Ratios are adjusted for: age, duration of angina and previous 
MI.
Odds ratios in the final column also adjusted for number of physician 
contacts over 12 months.
N, number of 'complete cases' included in regression analysis.
(number of physician contacts missing for 6 patients)BMC Health Services Research 2007, 7:142 http://www.biomedcentral.com/1472-6963/7/142
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narrow any gender differences. Furthermore, gender dif-
ferences in the clinical manifestation of CHD (as chronic
stable angina or acute coronary syndrome) may also
reflect underlying gender differences in the pathophysiol-
ogy of atherosclerosis and plaque morphology [31-33].
In relation to CHD therapy, the use of statins is most com-
monly reported aspect of the gender differences observed
in primary care [25-29,34]. Four studies have shown
lower levels of statin therapy in women with CHD [25-28]
and lower levels of cholesterol testing [25]. One study has
also demonstrated the persistence of gender differences,
for each and every year over a 6 year period (1997–2002),
in the use of statins, aspirin, beta-blockers and ACE inhib-
itors [28]. By contrast the 1998 Health Survey for England
found only minimal gender differences in the self-
reported use of statins [34]. Another study (which verified
the diagnoses of CHD against the medical records) also
found no important gender differences in cardiac risk fac-
tor recording or the use of secondary prevention therapy
such as statins [29]. This latter study also reported a higher
level of revascularisation for men [29]. Whilst not based
in primary care, the recent EuroHeart study (coordinated
across 24 European countries) found a higher perform-
ance of exercise ECG and coronary angiography in men
presenting to European cardiologists with stable angina
[35].
Study strengths and limitations
Our study has several important strengths. Firstly, experi-
enced CDMs extracted the data according to an agreed
protocol for a comprehensive range of measures that are
relevant to the primary care management of angina [24].
In the UK, primary care medical records are a valuable
source of information since they continuously collate
data, over a prolonged period of time within the National
Health Service (NHS), from both primary and secondary
care. Unlike previous studies, we accessed and reviewed
the complete primary care medical records to confirm that
the patients in this study had a 'clinically certain' physi-
cian diagnosis of angina [24,30]. Our dataset does not
allow us to assess the influence of physician gender on the
management of angina. In the UK patients are often regis-
tered under one primary care physician (for administra-
tive purposes), but actually consult a different physician
within the practice/partnership.
Secondly, we identified a large number of patients from a
diverse urban population receiving treatment for chronic
stable angina pectoris. UK clinical guidelines advocate
prescribing nitrates to all patients with 'clinically certain
angina' and nitrate prescribing is a useful marker for
chronic stable angina [24,30,36,37]. The prevalence of
angina in our study is comparable with other studies, sug-
gesting that we identified the majority of individuals
being treated for clinically certain angina [37-39]. Thirdly,
other than adjusting for previous MI we did not assess the
severity of CHD, or the presence of important co-morbid-
ities that might account for the differences that we found.
Although previous research suggests that women's angina
is often more disabling than men's [3,31,40,41], and that
the sexes have similar levels of co-morbidity (including
diabetes, hypertension and heart failure) [42]. An impor-
tant omission in our study is that no data was collected
concerning previous blood sugar measurements or the
presence of diabetes. At the time of the study, UK guide-
lines advocated the measurement of body mass index
(BMI) in the assessment of obesity. The measurement of
renal dysfunction (estimated glomerular filtration rate)
and waist/hip ratios in the routine assessment of patients
with CHD has only recently been advocated in the UK.
Our study has some important limitations. Firstly, our
sentinel practices were well-organised volunteers. Com-
pared with the city of Liverpool as a whole they generally
had smaller list sizes with more attached staff and younger
physicians. Consequently they may provide a higher than
usual standard of care. Previous studies have attempted to
avoid such volunteer bias by utilising data from all GP
practices in an urban area, but then compromised gener-
alisability by excluding those practices unable to provide
adequate data [29].
Secondly, our retrospective review of medical records
relies inherently upon data recorded as part of routine
clinical care. A prospective cohort study of incident cases
of angina would be a much stronger study design, but
would require considerably more resources. For example,
the identification of 1,000 incident cases of angina would
require the accurate surveillance of around 625,000 adults
for 12 months [23].
Thirdly, other than adjusting for previous MI we did not
assess the severity of CHD, nor the presence of important
co-morbidities which might account for the differences
that we found. Although previous research suggests that
women's angina is often more disabling than men's
[3,31,40,41], and that the sexes have similar levels of co-
morbidity (including diabetes, hypertension and heart
failure) [42]. An important omission in our study is that
no data was collected concerning previous blood sugar
measurements or the presence of diabetes. At the time of
the study, UK guidelines advocated the measurement of
body mass index (BMI) in the assessment of obesity. The
measurement of renal dysfunction (estimated glomerular
filtration rate) and waist/hip ratios in the routine assess-
ment of patients with CHD has only recently been advo-
cated in the UK.BMC Health Services Research 2007, 7:142 http://www.biomedcentral.com/1472-6963/7/142
Page 7 of 9
(page number not for citation purposes)
Finally, our diagnosis of angina pectoris is based on sub-
jective clinical judgement. Confirming the presence of
CHD in primary care in the UK can be problematic, both
in accessing cardiac investigations (such as exercise ECG
or angiography) and interpreting the results [31]. Even in
the absence of tests confirming cardiac ischaemia, 'nitrate
treated angina' is strongly associated with a relative
increase in the risk of death from CHD. A risk that is sim-
ilar for both men and women [42]. When we restricted
our analysis to the sub-group of patients with angina and
a previous MI and (a group of patients who have clearly
established the severity of their CHD) we observed the
same clinical pattern of gender differences. Men were still
significantly more likely to have their cardiac risk factors
recorded, receive secondary prevention, and undergo fur-
ther cardiac investigation and revascularisation. Although
our confidence intervals were inevitably wider due to the
smaller number of patients involved.
Gender differences in healthcare
Our study has demonstrated that important systematic
gender differences exist in the comprehensive clinical
management of patients with angina in primary care. Our
findings add support to the observation (in both the UK
and USA) that when presented with simulated clinical
vignettes, primary care physicians seem predisposed to
adopt a less favourable approach towards the clinical
management of women with cardiac symptoms com-
pared to men [20,21]. There are several possible explana-
tions as to why women may receive less favourable
cardiovascular healthcare than men [17,19,31,35] and
both biological and social factors are likely to be involved.
Gender differences exist in clinical presentation of cardio-
vascular symptoms, with 'atypical' presentations being
much commoner in women. The medical concept of 'clas-
sical angina' may disadvantage women since it is based
upon the 'typical' male presentation of exertional chest
pain. Diagnostic uncertainty is further exacerbated by a
higher false-positive rate of exercise tolerance testing
(ETT) in women. There are also widespread perceptions
(both lay and professional) that women have a lower risk
of developing CHD and a more favourable prognosis
when they do. The willingness to offer and accept cardio-
vascular therapy and intervention may be influenced by
the patients gender, whilst the technical challenge of oper-
ating on women's smaller coronary arteries may also
augur against surgical intervention [17,19,31,35]. Wider
social and cultural influences are also likely to play an
important role, since gender differences in the provision
of healthcare is not a phenomena that is solely restricted
to CHD. Women also receive less favourable clinical care
in relation to diabetes [43] and the performance of effec-
tive invasive procedures such a hip replacement and renal
transplantation [44]. The first step in addressing the gen-
der differences observed in the provision of CHD care is
the wider appreciation, by both professionals and the
public, of the existence of such differences along with a
more accurate perception of the risk posed to women by
CHD.
Clinically appropriate gender differences
It has been suggested that gender differences in the man-
agement of CHD may be clinically appropriate given
women's more atypical presentation, greater false positive
rate on exercise EGC testing and smaller coronary arteries
[31]. But in women in with clinically certain angina pec-
toris (explicitly and unequivocally labelled as having
angina pectoris by a physician) it is difficult to accept the
lower recording of cardiac risk factors and the lower use of
effective secondary prevention therapy as being clinically
appropriate. Major modifiable cardiac risk factors are
equally likely to be found in men and women with angina
[45] and there is no empirical evidence to suggest that sec-
ondary prevention therapy (with aspirin, statins, or beta-
blockers) is less effective in women than in men [8].
Changes in gender differences
This study was undertaken 18 months after the introduc-
tion of the National Service Framework for CHD in Eng-
land [46], yet the pattern of CHD gender differences
observed is largely unchanged from the one we observed
6 years earlier [22]. In relation to coronary revascularisa-
tion there has also been no appreciable narrowing of the
gender gap in either the USA or the UK [5,6] and a recent
Scottish study has reported a widening of the gender gap
in the use of secondary prevention therapy [28].
Conclusion
We have demonstrated that important gender differences
exist in the primary care management of chronic stable
angina in the UK. Women labelled with a clinical diagno-
sis of angina pectoris receive a lower level of risk factor
assessment, secondary prevention therapy, cardiac investi-
gation and coronary revascularisation. Such differences
are not due to the lower prevalence of a prior MI among
women, their older age or longer duration of angina. The
relatively high level of risk factor assessment in women,
although still below that for men, appears to be related to
their higher primary care consultation rate.
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